Diary

  • Mon
    18
    Jan
    2021
    Tue
    19
    Jan
    2021

    10am - 12.30pmOnline, live event


    Format:
    This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.

    Description:

    The aim of this course, spread over two mornings, is to provide learners with a good, general understanding of the concepts that underlie precision cancer medicine.

    The fundamental idea of precision medicine is to offer each cancer patient a treatment approach that is tailored to the unique biology and genetics of their disease. Elaine will explain how far we are able to do this by exploring the features of cancer we can target now, and where we might get to in the future. She will also look at when precision medicine falls down, and why expectations and realities don’t always align.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £50 per morning
    To book, contact: conferenceteam@rmh.nhs.uk
    View the programme for morning 1
    View the programme for morning 2

  • Tue
    02
    Feb
    2021
    Wed
    03
    Feb
    2021

    10am - 12.30pmOnline, live event


    Format:
    This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.


    Description:

    The aim of this course, spread over two mornings, is to provide learners with a good, general understanding of the biology, genetics and behaviours of many haematological cancers. Elaine also provides an up-to-date overview of modern systemic treatment approaches given to people with various haematological cancers. This includes CAR T cell therapy and other targeted approaches that have come through clinical trials in recent years.

    Elaine's goal is to explain the science that underpins each treatment. She also hopes to provide learners with a broad understanding of why treatments work well for some patients but not for others.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £50 per morning
    To book, contact: conferenceteam@rmh.nhs.uk

    View the programme for morning 1

    View the programme for morning 2

  • Mon
    26
    Apr
    2021
    Tue
    27
    Apr
    2021

    10am - 1pmOnline, live event

     

    Format: This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.

    Description: Over the course of two mornings, Elaine will guide you through many of the most relevant topics relating to modern systemic treatments for non-small cell lung cancer (NSCLC).
    The first morning’s focus is on the gene faults that drive many NSCLCs and on the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET and RET.
    The second morning is about cancer’s relationship with the immune system and on the checkpoint inhibitor group of immunotherapies, which include PD-1, PD-L1 and CTLA-4 targeted antibody therapies.
    As ever, Elaine's presentations are full of colourful and enlightening illustrations to help you make sense of scientific concepts. Her descriptions avoid unnecessary jargon and are pitched so that even those with a relatively limited understanding of cell biology are able to understand (if you don't understand the relationship between DNA, genes and proteins, do look this up beforehand).

    View the programme for morning 1

    View the programme for morning 2

    Audience: This content is ideal for research nurses, clinical nurse specialists, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with lung cancer.

    Cost: £50 per morning; the content will be available for 30 days after the event

    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2921